Global Rare Disease Diagnostics Market is Projected to Hit USD 88,969.27 Million by 2032, With a CAGR of 9.2% From 2024 to 2032- Report by Polaris Market Research (PMR) [Yahoo! Finance]
Centogene N.V. - Common Shares (CNTG)
Last centogene n.v. - common shares earnings: 12/5 06:28 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
New York, May 23, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global Rare Disease Diagnostics Market size is projected to grow from USD 40,227.42 million in 2023 to USD 88,969.27 million by 2032, at a compound annual growth rate (CAGR) of 9.2% during the forecast period. A critical component of healthcare is the identification of rare diseases, which focuses on finding and treating illnesses that only afflict a small portion of the population. A rare disease, sometimes referred to as an orphan disease, is distinguished by a wide variety of symptoms that change not only from condition to condition but also from patient to patient suffering from an identical condition. Moreover, even if each rare disease is uncommon on its own, millions of people are affected by rare diseases globally, which makes diagnosis and treatment extremely difficult. Complex genetic, biochemical, or environmental variables are frequently involved in many disorders, requiring specialist diagnostic techni
Show less
Read more
Impact Snapshot
Event Time:
CNTG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNTG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNTG alerts
High impacting Centogene N.V. - Common Shares news events
Weekly update
A roundup of the hottest topics
CNTG
News
- C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development [Yahoo! Finance]Yahoo! Finance
- C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug DevelopmentGlobeNewswire
- CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting [Yahoo! Finance]Yahoo! Finance
- CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General MeetingGlobeNewswire
- CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
CNTG
Sec Filings
- 6/20/24 - Form 6-K
- 5/31/24 - Form 6-K
- 5/29/24 - Form 6-K
- CNTG's page on the SEC website